Agios has assembled a world-class scientific advisory board that includes renowned experts in cancer metabolism, oncology, drug discovery and translational medicine. These advisors work in close collaboration with Agios scientists to identify new research directions and accelerate Agios' target validation and drug discovery programs.
Craig B. Thompson, M.D.
Chair of the scientific advisory board, Memorial Sloan-Kettering Cancer Center
Joan Brugge, Ph.D.
Harvard Medical School
Lewis C. Cantley, Ph.D.
Beth Israel Deaconess Medical Center and Harvard Medical School
Jeffrey Engelman, M.D., Ph.D.
Massachusetts General Hospital and Harvard Medical School
William G. Kaelin Jr., M.D.
Dana-Farber Cancer Institute and Harvard Medical School
Tak W. Mak, Ph.D.
University of Toronto and the Campbell Family Institute for Breast Cancer Research
Pier Paolo Pandolfi, M.D., Ph.D.
Beth Israel Deaconess Medical Center
David M. Sabatini, M.D., Ph.D.
Whitehead Institute and Massachusetts Institute of Technology
Charles Sawyers, M.D.
Memorial Sloan-Kettering Cancer Center
Matthew Vander Heiden, M.D., Ph.D.
Koch Institute for Integrative Cancer Research at MIT